SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 7, 2026

INCY

INCYTE CORP
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $2.2M total
Actionable Insight • Neutral

The insider selling is immaterial and likely post-earnings routine activity. Monitor for any larger open-market sales by C-suite executives, but this cluster alone warrants no trading action.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$121.55
T+0 close · Aug 7, 2026 · via day close
Latest settled
−3.26%
T+60 · $117.59
Vs SPY
−0.84%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 10 $121.55entry
  2. T+1 · 3mo ago −0.39%α −0.08% · $121.07
  3. T+5 · 3mo ago +1.60%α +1.65% · $123.50
  4. T+20 · 2mo ago +2.34%α +3.26% · $124.40
  5. T+60 · 13d ago −3.26%α −0.84% · $117.59
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two senior R&D executives at Incyte (President and Chief Scientific Officer) sold a combined $2.18M of stock in the week following the Q2 earnings beat. The sales are trivial relative to Incyte's $24B market cap (0.009%) and likely reflect routine post-earnings window rebalancing and derivative exercise coverage, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$2.2M
Insiders
2

Key Facts

  • Pablo J. Cagnoni (President, Global Head of R&D) sold $1.90M on 2026-07-31; Patrick A. Mayes (EVP & Chief Scientific Officer) sold ~$274K on 2026-08-05 after exercising options
  • Total cluster value: $2.18M (0.009% of $24B market cap)
  • Cluster occurred 3–10 days after Incyte's Q2 2026 earnings (8-K filed 7/28), which beat consensus but included a one-time CMS settlement benefit
  • Mayes' sales corresponded with derivative exercises at $105–$106 strike, suggesting tax- or exercise-cost coverage

Financial Impact

Trivial insider selling, $2.18M total vs $24B market cap (0.009%). No material impact.

insider holdings

Risk Factors

  • Larger insider sales in coming weeks could shift sentiment
  • Q2 earnings beat was partly one-time; future quarters may not sustain the same earnings power

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research
Analyst Consensus
52% bullish (33 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-INCY-1786132957799

US Market Status

Market Closed · Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 7, 2026